Page last updated: 2024-09-04

docetaxel anhydrous and cepharanthine

docetaxel anhydrous has been researched along with cepharanthine in 1 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (cepharanthine)	Trials (cepharanthine)	Recent Studies (post-2010) (cepharanthine)
12,110	3,216	6,920	340	7	116

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, C; De Souza, R; Huynh, L; Piquette-Miller, M; Zahedi, P	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and cepharanthine

Article	Year
Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer. Molecular pharmaceutics, 2011, Feb-07, Volume: 8, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, SCID; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Taxoids	2011

Article

Year

Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer.

Molecular pharmaceutics, 2011, Feb-07, Volume: 8, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, SCID; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Taxoids

2011